Eiposurc-Efficacy Outcome Modeling far Danagliflozin, An Orally Selective SGLT2 Inhibitor, In Patients With Type 2 Diabetes Mellitus: 69


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles